| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
904 A Comparison of Races and Leukemia Subtypes among Patients in Different Cancer Survivorship Phases
|
Pandya, Devesh
|
|
2011
|
11 |
S1 |
p. S135-S136
2 p.
|
artikel
|
| 2 |
A Comparison of Races and Leukemia Subtypes Among Patients in Different Cancer Survivorship Phases
|
Pandya, Devesh M.
|
|
2011
|
11 |
S1 |
p. S114-S118
5 p.
|
artikel
|
| 3 |
510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation
|
Malik, Asifa
|
|
2011
|
11 |
S1 |
p. S128-S129
2 p.
|
artikel
|
| 4 |
Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors
|
Champlin, Richard
|
|
2011
|
11 |
S1 |
p. S96-S100
5 p.
|
artikel
|
| 5 |
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: Critical for Cure?
|
de Witte, Theo
|
|
2011
|
11 |
S1 |
p. S46-S48
3 p.
|
artikel
|
| 6 |
507 A Novel Mechanism of Fas Signaling Suppression by PMLRARα in Acute Promyelocytic Leukemia
|
Tao, Rong-Hua
|
|
2011
|
11 |
S1 |
p. S127-S128
2 p.
|
artikel
|
| 7 |
503 Antagonizing Inhibitors of Apoptosis (IAP) Family of Proteins Sensitizes AML to Chemotherapy-Induced Apoptosis
|
Mak, Duncan
|
|
2011
|
11 |
S1 |
p. S125-S126
2 p.
|
artikel
|
| 8 |
Array Comparative Genomic Hybridization Analysis Identifies Recurrent Gain of Chromosome 2p25.3 Involving the ACP1 and MYCN Genes in Chronic Lymphocytic Leukemia
|
Ma, Deqin
|
|
2011
|
11 |
S1 |
p. S17-S24
8 p.
|
artikel
|
| 9 |
BCR-ABL1—Negative Myeloproliferative Neoplasms: A Review of Molecular Biology, Diagnosis, and Treatment
|
Vakil, Erik
|
|
2011
|
11 |
S1 |
p. S37-S45
9 p.
|
artikel
|
| 10 |
903 Bone Marrow Derived Human Mesenchymal Stem Cells have the Capacity to Differentiate into B-Cells in Vivo
|
Wang, Rui-yu
|
|
2011
|
11 |
S1 |
p. S135-
1 p.
|
artikel
|
| 11 |
**101 CCL3 (MIP-1 α) Plasma Levels and the Risk for Disease Progression in Chronic Lymphocytic Leukemia (CLL)
|
Sivina, Mariela
|
|
2011
|
11 |
S1 |
p. S119-
1 p.
|
artikel
|
| 12 |
**102 Chemoimmunotherapy with Ofatumumab, Fludarabine and Cyclophosphamide (O-FC) in Previously Untreated Patients with Chronic Lymphocytic Leukemia
|
Wierda, William G.
|
|
2011
|
11 |
S1 |
p. S119-S120
2 p.
|
artikel
|
| 13 |
Chlorambucil—Still Not Bad: A Reappraisal
|
Catovsky, Daniel
|
|
2011
|
11 |
S1 |
p. S2-S6
5 p.
|
artikel
|
| 14 |
704 Cold-Agglutinin Hemolytic Anemia: A Harbinger of Recurrent Lymphoma
|
Brammer, Jonathan
|
|
2011
|
11 |
S1 |
p. S132-
1 p.
|
artikel
|
| 15 |
Continuing Medical Education Post-Test[Course Code: MEMV 1092]
|
|
|
2011
|
11 |
S1 |
p. S137-S140
4 p.
|
artikel
|
| 16 |
804 Dasatinib Combined with Interferon-α Achieves a Complete Cytogenetic Response (CCyR) and Major Molecular Response (MMR) in a Patient with Chronic Myelogenous Leukemia (CML) Harboring the T315I BCR-ABL1 Mutation
|
Cornelison, A. Megan
|
|
2011
|
11 |
S1 |
p. S133-S134
2 p.
|
artikel
|
| 17 |
Dasatinib Combined with Interferon-alfa Induces a Complete Cytogenetic Response and Major Molecular Response in a Patient with Chronic Myelogenous Leukemia Harboring the T315I BCR-ABL1 Mutation
|
Cornelison, A. Megan
|
|
2011
|
11 |
S1 |
p. S111-S113
3 p.
|
artikel
|
| 18 |
**504 Detection of Cytogenetic Abnormalities Associated with Outcome Differences in Acute Myeloid Leukemia Using Array-Based Comparative Genomic Hybridization (aCGH) Analysis
|
Patel, Keyur
|
|
2011
|
11 |
S1 |
p. S126-
1 p.
|
artikel
|
| 19 |
*701 Detection of Minimal Residual Disease Following Induction Immunochemotherapy Predicts Progression Free Survival in Mantle Cell Lymphoma: Final Results of CALGB 59909
|
Liu, Hongtao
|
|
2011
|
11 |
S1 |
p. S130-S131
2 p.
|
artikel
|
| 20 |
*401 Distribution and Significance of EZH2 Mutations in MDS and Related Myeloid Malignancies
|
Makishima, Hideki
|
|
2011
|
11 |
S1 |
p. S125-
1 p.
|
artikel
|
| 21 |
Editorial Board/Masthead
|
|
|
2011
|
11 |
S1 |
p. A7-
1 p.
|
artikel
|
| 22 |
Fatal Paraneoplastic Systemic Leukocytoclastic Vasculitis as a Presenting Feature of Chronic Lymphocytic Leukemia
|
Lulla, Premal
|
|
2011
|
11 |
S1 |
p. S14-S16
3 p.
|
artikel
|
| 23 |
105 Fatal Paraneoplastic Systemic Leukocytoclastic Vasculitis as a Presenting Feature of Chronic Lymphocytic Leukemia
|
Lulla, Premal
|
|
2011
|
11 |
S1 |
p. S121-
1 p.
|
artikel
|
| 24 |
Fludarabine Versus Chlorambucil: Is the Debate Over?
|
Rai, Kanti R.
|
|
2011
|
11 |
S1 |
p. S7-S9
3 p.
|
artikel
|
| 25 |
103 Gain of Chromosome 2p25.3 Involving the ACP1 Gene is Frequent in Chronic Lymphocytic Leukemia
|
Ma, Deqin
|
|
2011
|
11 |
S1 |
p. S120-
1 p.
|
artikel
|
| 26 |
High-Risk Multiple Myeloma: Does it Still Exist?
|
Tuchman, Sascha A.
|
|
2011
|
11 |
S1 |
p. S70-S76
7 p.
|
artikel
|
| 27 |
HSP90 Inhibitors as Therapy for Multiple Myeloma
|
Usmani, Saad Z.
|
|
2011
|
11 |
S1 |
p. S77-S81
5 p.
|
artikel
|
| 28 |
**511 Hsp90 Inhibitor STA-9090 Down-Regulates Expression of Hsp90 Client Protein WT1 in Myeloid Leukemia Cells
|
Padmanabhan, Swaminathan
|
|
2011
|
11 |
S1 |
p. S129-
1 p.
|
artikel
|
| 29 |
203 Hypoxic Leukemic Microenvironment and its Targeting by the Hypoxia-Activated Prodrug PR-104
|
Benito, Juliana
|
|
2011
|
11 |
S1 |
p. S124-
1 p.
|
artikel
|
| 30 |
703 IGF-IR Tyrosine Kinase as a Novel Molecular Target to Eradicate Mantle Cell Lymphoma
|
Vishwamitra, Deeksha
|
|
2011
|
11 |
S1 |
p. S131-S132
2 p.
|
artikel
|
| 31 |
801 IL3R Directed Agents, SL-401 and SL-501, Inhibit the Growth of Leukemia Stem Cells in CML
|
Frolova, Olga
|
|
2011
|
11 |
S1 |
p. S132-S133
2 p.
|
artikel
|
| 32 |
110 Incidence of Chronic B-Cell Leukemia in Patients with CTCL
|
Singh, Lotika
|
|
2011
|
11 |
S1 |
p. S123-
1 p.
|
artikel
|
| 33 |
602 Is There a Role for Allografting in Myeloma in the Era of New Drugs?: Long-Term Follow-Up of a Comparative Study
|
Bruno, Benedetto
|
|
2011
|
11 |
S1 |
p. S130-
1 p.
|
artikel
|
| 34 |
JAK2 Inhibitors: Are They the Solution?
|
Santos, Fabio P.S.
|
|
2011
|
11 |
S1 |
p. S28-S36
9 p.
|
artikel
|
| 35 |
201 Kefir Induces Cell-Cycle Arrest and Apoptosis in HTLV-1 Negative Malignant T-Lymphocytes
|
Rizk, Sandra
|
|
2011
|
11 |
S1 |
p. S123-
1 p.
|
artikel
|
| 36 |
*104 LDOC1 mRNA Is Differentially Expressed in Chronic Lymphocytic Leukemia and Predicts Overall Survival in Untreated Patients
|
Duzkale, Hatice
|
|
2011
|
11 |
S1 |
p. S120-S121
2 p.
|
artikel
|
| 37 |
Management of Myeloma: An Italian Perspective
|
Bruno, Benedetto
|
|
2011
|
11 |
S1 |
p. S82-S86
5 p.
|
artikel
|
| 38 |
Management Options for Follicular Lymphoma: Observe; R-CHOP; B-R; Others?
|
McLaughlin, Peter
|
|
2011
|
11 |
S1 |
p. S91-S95
5 p.
|
artikel
|
| 39 |
**107 Monitoring of Innate Cellular Immune Responses in Chronic Lymphocytic Leukemia (CLL)-A Pilot Study
|
Lewis, Russell E.
|
|
2011
|
11 |
S1 |
p. S121-S122
2 p.
|
artikel
|
| 40 |
Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia: Methods and Best Applications
|
Jorgensen, Jeffrey L.
|
|
2011
|
11 |
S1 |
p. S49-S53
5 p.
|
artikel
|
| 41 |
900 Multipotent Mesenchymal Stromal Cells (MSC) - Evolving Role in Cancer and Leukemia Therapy
|
Andreeff, Michael
|
|
2011
|
11 |
S1 |
p. S134-S135
2 p.
|
artikel
|
| 42 |
New Treatments and Strategies in Acute Myeloid Leukemia
|
Ravandi, Farhad
|
|
2011
|
11 |
S1 |
p. S60-S64
5 p.
|
artikel
|
| 43 |
Non-Hodgkin's Lymphoma: The Old and the New
|
Cabanillas, Fernando
|
|
2011
|
11 |
S1 |
p. S87-S90
4 p.
|
artikel
|
| 44 |
Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry
|
Juliusson, Gunnar
|
|
2011
|
11 |
S1 |
p. S54-S59
6 p.
|
artikel
|
| 45 |
Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure
|
Cornelison, A. Megan
|
|
2011
|
11 |
S1 |
p. S101-S110
10 p.
|
artikel
|
| 46 |
802 Overcoming Imatinib Resistance by Targeting XIAP and ARC (Apoptosis Repressor with Caspase Recruitment Domain) in Blast Crisis CML Cells
|
Carter, Bing
|
|
2011
|
11 |
S1 |
p. S133-
1 p.
|
artikel
|
| 47 |
506 p53 Activation of Mesenchymal Stromal Cells (MSC) Partially Abrogates Microenvironment-Mediated Resistance to FLT3 Inhibition in FLT3/ITD AML
|
Kojima, Kensuke
|
|
2011
|
11 |
S1 |
p. S127-
1 p.
|
artikel
|
| 48 |
Prognostic Factors and Models in Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis
|
Passamonti, Francesco
|
|
2011
|
11 |
S1 |
p. S25-S27
3 p.
|
artikel
|
| 49 |
Retrospect of Hematologic Malignancies 2010
|
Cortés, Jorge E.
|
|
2011
|
11 |
S1 |
p. S1-
1 p.
|
artikel
|
| 50 |
505 Role for PP2A Regulatory Subunit B55alpha as a Regulator of AKT and Other Signaling Pathways in AML
|
Ruvolo, Peter
|
|
2011
|
11 |
S1 |
p. S126-S127
2 p.
|
artikel
|
| 51 |
702 Stem-Like Tumor Cells Confer Drug Resistant Properties to Mantle Cell Lymphoma
|
Jung, Hyun-Joo
|
|
2011
|
11 |
S1 |
p. S131-
1 p.
|
artikel
|
| 52 |
Table of Contents
|
|
|
2011
|
11 |
S1 |
p. A9-A11
nvt p.
|
artikel
|
| 53 |
Targeting the Bone Marrow in Waldenstrom Macroglobulinemia
|
Ghobrial, Irene M.
|
|
2011
|
11 |
S1 |
p. S65-S69
5 p.
|
artikel
|
| 54 |
601 The Antimyeloma Activity of PU-H71, a Novel Purine Scaffold HSP90 Inhibitor, is via Inhibition of Both HSP90A and HSP90B1
|
Usmani, Saad
|
|
2011
|
11 |
S1 |
p. S129-S130
2 p.
|
artikel
|
| 55 |
509 The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia
|
Cortes, Jorge
|
|
2011
|
11 |
S1 |
p. S128-
1 p.
|
artikel
|
| 56 |
202 The Reduced and Altered Activities of PAX5 are Linked to the Protein-Protein Interaction Motif (Coiled-Coil Domain) of the PAX5-PML Fusion Protein in t(9;15)-Associated Acute Lymphocytic Leukemia
|
Qiu, Jihui
|
|
2011
|
11 |
S1 |
p. S124-
1 p.
|
artikel
|
| 57 |
501 The Role of STAT3 Pathway in the MLL-Fusion Mediated Transformation
|
Chu, Huimin
|
|
2011
|
11 |
S1 |
p. S125-
1 p.
|
artikel
|
| 58 |
108 Unusual Autoimmune Complications in Chronic Lymphocytic Leukemia
|
Jung, Moonjung
|
|
2011
|
11 |
S1 |
p. S122-
1 p.
|
artikel
|
| 59 |
Unusual Autoimmune Nonhematologic Complications in Chronic Lymphocytic Leukemia
|
Jung, Moonjung
|
|
2011
|
11 |
S1 |
p. S10-S13
4 p.
|
artikel
|
| 60 |
109 XMRV: Virological, Immunological and Clinical Correlations in a Patient with Chronic Lymphocytic Leukemia
|
Snyderman, Michael
|
|
2011
|
11 |
S1 |
p. S122-S123
2 p.
|
artikel
|
Tijdschrift beschrijving